Hakutulokset - José-Luis Molinuevo

Tarkenna hakua
  1. 1
    Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias

    Memantine: Targeting glutamate excitotoxicity in Alzheimer's disease and other dementias Tekijä José Luís Molinuevo, Albert Lladó, Lorena Rami

    Julkaistu 2005
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Plant-Rich Dietary Patterns, Plant Foods and Nutrients, and Telomere Length

    Plant-Rich Dietary Patterns, Plant Foods and Nutrients, and Telomere Length Tekijä Marta Crous‐Bou, José-Luis Molinuevo, Aleix Sala‐Vila

    Julkaistu 2019
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease

    Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease Tekijä Marta Milà‐Alomà, Marc Suárez‐Calvet, José Luís Molinuevo

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Alzheimer’s disease prevention: from risk factors to early intervention

    Alzheimer’s disease prevention: from risk factors to early intervention Tekijä Marta Crous‐Bou, Carolina Minguillón, Nina Gramunt, José Luís Molinuevo

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy

    Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy Tekijä Alireza Atri, José Luís Molinuevo, Ole Lemming, Yvonne Wirth, Irena Pulte, David Wilkinson

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol

    European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol Tekijä Alina Solomon, Miia Kivipelto, José Luís Molinuevo, Brian D. M. Tom, Craig Ritchie

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease

    A whole-brain computational modeling approach to explain the alterations in resting-state functional connectivity during progression of Alzheimer's disease Tekijä Murat Demirtaş, Carles Falcón, Alan Tucholka, Juan Domingo Gispert, José Luís Molinuevo, Gustavo Deco

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis

    Cumulative, additive benefits of memantine-donepezil combination over component monotherapies in moderate to severe Alzheimer’s dementia: a pooled area under the curve analysis Tekijä Alireza Atri, Suzanne Hendrix, Vojislav Pejović, Robert K. Hofbauer, John Edwards, José Luís Molinuevo, Stephen M. Graham

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    THE EUROPEAN PREVENTION OF ALZHEIMER’S DEMENTIA (EPAD) LONGITUDINAL COHORT STUDY: BASELINE DATA RELEASE V500.0

    THE EUROPEAN PREVENTION OF ALZHEIMER’S DEMENTIA (EPAD) LONGITUDINAL COHORT STUDY: BASELINE DATA RELEASE V500.0 Tekijä C.W. Ritchie, Graciela Muñiz‐Terrera, Miia Kivipelto, Alina Solomon, Brian D. M. Tom, José Luís Molinuevo

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer’s disease

    Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer’s disease Tekijä Stavros Skouras, Carles Falcón, Alan Tucholka, Lorena Rami, Raquel Sánchez‐Valle, Albert Lladó, Juan Domingo Gispert, José Luís Molinuevo

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers

    Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers Tekijä Juan Fortea, Roser Sala‐Llonch, David Bartrés‐Faz, Beatríz Bosch, Albert Lladó, Núria Bargalló, José Luís Molinuevo, Raquel Sánchez‐Valle

    Julkaistu 2010
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease

    Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease Tekijä Christoffer Rosén, Carl-Henrik Andersson, Ulf Andréasson, José Luís Molinuevo, Maria Bjerke, Lorena Rami, Albert Lladó, Kaj Blennow, Henrik Zetterberg

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease

    Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease Tekijä Piotr Lewczuk, Anja Matzen, Kaj Blennow, Lucilla Parnetti, José Luís Molinuevo, Paolo Eusebi, Johannes Kornhuber, John C. Morris, Anne M. Fagan

    Julkaistu 2016
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Episodic memory and executive functions in cognitively healthy individuals display distinct neuroanatomical correlates which are differentially modulated by aging

    Episodic memory and executive functions in cognitively healthy individuals display distinct neuroanatomical correlates which are differentially modulated by aging Tekijä Raffaele Cacciaglia, José Luís Molinuevo, Gonzalo Sánchez‐Benavides, Carles Falcón, Nina Gramunt, Anna Brugulat‐Serrat, Oriol Grau‐Rivera, Juan Domingo Gispert

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease

    Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease Tekijä Alireza Atri, Lutz Frölich, Clive Ballard, Pierre N. Tariot, José Luís Molinuevo, Neli Boneva, Kristian Windfeld, Lars Lau Rakêt, Jeffrey L. Cummings

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

    Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic Tekijä Harald Hampel, Sid E. O’Bryant, José Luís Molinuevo, Henrik Zetterberg, Colin L. Masters, Simone Lista, Steven J. Kiddle, Richard Batrla, Kaj Blennow

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort

    Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort Tekijä Gonzalo Sánchez‐Benavides, Oriol Grau‐Rivera, Marc Suárez‐Calvet, Carolina Minguillón, Raffaele Cacciaglia, Nina Gramunt, Carles Falcón, Juan Domingo Gispert, José Luis Molinuevo

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm<sup>2</sup>) in Alzheimer’s Disease

    Randomized, Double-Blind, Parallel-Group, 48-Week Study for Efficacy and Safety of a Higher-Dose Rivastigmine Patch (15 vs. 10 cm<sup>2</sup>) in Alzheimer’s Disease Tekijä Jeffrey L. Cummings, Lutz Froelich, Sandra E. Black, Serge Bakchine, Giuseppe Bellelli, José Luís Molinuevo, Reto W. Kressig, Pamela Downs, Angelika Caputo, Christine Strohmaier

    Julkaistu 2012
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

    Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis Tekijä Federica Cacciamani, Marion Houot, Geoffroy Gagliardi, Bruno Dubois, Sietske A.M. Sikkes, Gonzalo Sánchez‐Benavides, Elena Denicolò, José Luís Molinuevo, Patrizia Vannini, Stéphane Epelbaum

    Julkaistu 2021
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Dementia care during COVID-19

    Dementia care during COVID-19 Tekijä Huali Wang, Tao Li, Paola Barbarino, Serge Gauthier, Henry Brodaty, José Luís Molinuevo, Hengge Xie, Yongan Sun, Enyan Yu, Yanqing Tang, Wendy Weidner, Xin Yu

    Julkaistu 2020
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: